Biomarker levels in gingival crevicular fluid of generalized aggressive periodontitis patients after non-surgical periodontal treatment

Clinical Oral Investigations

Volumn 22, Issue 2, 2018, Pages 1083-1092

  Romano, Federica ^a   Bongiovanni, Loretta ^a   Bianco, Laura ^a   Di Scipio, Federica ^a   Yang, Zhiqian ^a   Sprio, Andrea Elio ^a   Berta, Giovanni Nicolao ^a   Aimetti, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Aggressive periodontitis; Gingival crevicular fluid; Inflammatory mediators; Periodontal therapy

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 85029501796     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-017-2192-1     Document Type: Article

References (49)

1. Meng H, Xu L, Li Q, Han J, Zhao Y (2007) Determinants of host susceptibility in aggressive periodontitis. Periodontol 2000 43:133–159
2. Kinane DF, Hart TC (2003) Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med 14:430–449
3. Liu RK, Cao CF, Meng HX, Gao Y (2001) Polymorphonuclear neutrophils and their mediators in gingival tissues from genereralized aggressive periodontitis. J Periodontol 72:1545–1553
4. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38:210–217
5. Rescala B, Rosalem W Jr, Teles RP, Fischer RG, Haffajee AD, Socransky SS, Gustafsson A, Figueredo CM (2010) Immunologic and microbiologic profiles of chronic and aggressive periodontitis subjects. J Periodontol 81:1308–1316
6. Lamster IB, Novak MJ (1992) Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 3:31–60
7. Giannopoulou C, Kamma JJ, Mombelli A (2003) Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 30:145–153
8. Toyman U, Tüter G, Kurtiş B, Kıvrak E, Bozkurt Ş, Yücel AA, Serdar M (2015) Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor-2, matrix metalloproteinase-3 and interleukin 1-ß in patients with different periodontal diseases. J Periodontal Res 50:44–51
9. Ertugrul AS, Sahin H, Dikilitas A, Alpaslan N, Bozoglan A (2013) Comparison of CCL28, interleukin-8, interleukin-1ß and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis. J Periodontal Res 48:44–51
10. Duarte PM, Bastos MF, Fermiano D, Rabelo CC, Perez-Chaparro PJ, Figueiredo LC, Faveri M, Feres M (2015) Do subjects with aggressive and chronic periodontitis exhibit a different cytokine/chemokine profile in the gingival crevicular fluid? A systematic review. J Periodontal Res 50:18–27
11. Thunell DH, Tymkiw KD, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, Brogden KA, Guthmiller JM (2010) A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res 45:148–152
12. Toker H, Poyraz O, Eren K (2008) Effect of periodontal treatment on IL-1beta, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J Clin Periodontol 35:507–513
13. Rosalem W, Rescala B, Teles RP, Fischer RG, Gustaffson A, Figueredo CM (2011) Effect of non-surgical treatment on chronic and aggressive periodontitis: clinical, immunologic and microbiologic findings. J Periodontol 82:979–989
14. de Lima Oliveira AP, de Faveri M, Gursky LC, Mestnik MJ, Feres M, Haffajee AD, Socransky SS, Teles RP (2012) Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol 39:295–302
15. Chapple CC, Kumar RK, Hunter N (2000) Vascular remodelling in chronic inflammatory periodontal disease. J Oral Pathol Med 29:500–506
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039
17. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E (1998) Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 33:491–499
18. Pradeep A, Prapulla D, Sharma A, Sujatha PB (2011) Gingival crevicular fluid and serum vascular endothelial growth factor: their relationship in periodontal health, disease and after treatment. Cytokine 54:200–204
19. Prapulla DV, Sujatha PB, Pradeep AR (2007) Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol 78:1783–1787
20. Padma R, Sreedhara A, Indeevar P, Sarkar I, Kumar CS (2014) Vascular endothelial growth factor levels in gingival crevicular fluid before and after periodontal therapy. J Clin Diagn Res 8(11):ZC75–ZC79
21. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283–1316
22. Gamal AY, El-Shal OS, El-Aasara MM, Fakhry EM (2011) Platelet-derived growth factor-BB release in gingival crevicular fluid after use of marginal periosteal pedicle graft as an autogenous guided tissue membrane to treat localized intrabony defects. J Periodontol 82:272–280
23. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607–12613
24. Graves DT, Cochran D (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74:391–401
25. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501
26. Gemmell E, Seymour GJ (2004) Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 35:21–41
27. Jäger A, Kuchroo VK (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72:173–184
28. Li H, Rostami A (2010) IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J NeuroImmune Pharmacol 5:198–209
29. Arana AM, Repeke CE, Garlet TP, Vieira AE, Campanelli AP, Trombone AP, Letra A, Silva RM, Garlet GP (2013) Evidence supporting a protective role for Th9 and Th22 cytokines in human and experimental periapical lesions. J Endod 39:83–87
30. Araujo-Pires AC, Francisconi CF, Biguetti CC, Cavalla F, Aranha AM, Letra A, Trombone AP, Faveri M, Silva RM, Garlet GP (2014) Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22 Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci 22:336–346
31. de Queiroz AC, Taba M Jr, O’Connell PA, da Nóbrega PB, Costa PP, Kawata VK, Trevisan GL, Novaes AB Jr, de Souza SL, Palioto DB, Grisi MF (2008) Inflammation markers in healthy and periodontitis patients: a preliminary data screening. Braz Dent J 19:3–8
32. Bastos MF, Lima JA, Vieira PM, Mestnik MJ, Faveri M, Duarte PM (2009) TNF-α and IL-4 levels in generalized aggressive periodontitits subjects. Oral Dis 15:82–87
33. Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6
34. Löe H (1967) The gingival index, the plaque index, and the retention index systems. J Periodontol 38(Suppl):610–616
35. Tözüm TF, Hatipoğlu H, Yamalik N, Gürsel M, Alptekin NO, Ataoğlu T, Marakoğlu I, Gürsoy UK, Eratalay K (2004) Critical steps in electronic volume quantification of gingival crevicular fluid: the potential impact of evaporation, fluid retention, local conditions and repeated measurements. J Periodontal Res 39:344–357
36. Kulkarni C, Kinane DF (2014) Host response in aggressive periodontitis. Periodontol 65:79–91
37. Pinchpack JS, Taylor BA, Gibbins JR, Hunter N (1996) Microvascular angiopathy in advanced periodontal disease. J Pathol 179:204–209
38. Zoellner H, Hunter N (1991) Vascular expansion in chronic periodontitis. J Oral Pathol Med 20:433–437
39. Vasconcelos RC, Costa Ade L, Freitas Rde A, Bezerra BA, Santos BR, Pinto LP, Gurgel BC (2016) Immunoexpression of HIF-1α and VEGF in periodontal disease and healthy gingival tissues. Braz Dent J 27:117–122
40. Güneri P, Unlü F, Yeşilbek B, Bayraktar F, Kokuludağ A, Hekimgil M, Boyacioğlu H (2004) Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol 75:91–97
41. Johnson RB, Serio FG, Dai X (1999) Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 70:848–852
42. Cetinkaya BO, Keles GC, Ayas B, Sakallioglu EE, Acikgoz G (2007) The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol 78:1129–1135
43. Hung HC, Douglass CW (2002) Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol 29:975–986
44. Doxey DL, Cutler CW, Iacopino AM (1998) Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model. J Periodontol 69:113–119
45. Pinheiro ML, Feres-Filho EJ, Graves DT, Takiya CM, Elsas MI, Elsas PP, Luz RA (2003) Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients. J Periodontol 74:323–328
46. (3) and inteleukin-1beta in patients with aggressive periodontitis. J Periodontol 81:260–266
47. Engebretson SP, Lamster IB, Herrera-Abreu M, Celenti RS, Timms JM, Chaudhary AG, di Giovine FS, Kornman KS (1999) The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 70:567–573
48. Al-Shammari KF, Giannobile WV, Aldredge WA, Iacono VJ, Eber RM, Wang HL, Oringer RJ (2001) Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J Periodontol 72:1045–1051
49. Yoshinari N, Kawase H, Mitani A, Ito M, Sugiishi S, Matsuoka M, Shirozu N, Ishihara Y, Bito B, Hiraga M, Arakawa K, Noguchi T (2004) Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1beta in gingival crevicular fluid and gingival tissues. J Periodontal Res 39:158–167